| 0 |
l-Thyroxine [EPC] |
1 |
0.0204 |
| 1 |
Antiparasitic [EPC] |
2 |
0.0004 |
| 2 |
Pediculicide [EPC] |
2 |
0.0004 |
| 3 |
Oxytocic [EPC] |
1 |
0.0003 |
| 4 |
Prostaglandin Analog [EPC] |
24 |
0.0003 |
| 5 |
Carbonic Anhydrase Inhibitor [EPC] |
4 |
0.0002 |
| 6 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
1 |
0.0002 |
| 7 |
Topoisomerase Inhibitor [EPC] |
10 |
0.0001 |
| 8 |
General Anesthetic [EPC] |
3 |
0.0001 |
| 9 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
6 |
0.0001 |
| 10 |
Cholinesterase Inhibitor [EPC] |
1 |
0.0001 |
| 11 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 12 |
Ester Local Anesthetic [EPC] |
2 |
0.0000 |
| 13 |
Interleukin-6 Receptor Antagonist [EPC] |
5 |
0.0000 |
| 14 |
Amide Local Anesthetic [EPC] |
3 |
0.0000 |
| 15 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 16 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
3 |
0.0000 |
| 17 |
Xanthine Oxidase Inhibitor [EPC] |
5 |
0.0000 |
| 18 |
Non-Standardized Chemical Allergen [EPC] |
2 |
0.0000 |
| 19 |
CTLA-4-directed Blocking Antibody [EPC] |
1 |
0.0000 |
| 20 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Acetylcholine Release Inhibitor [EPC] |
2 |
0.0000 |
| 22 |
Antiarrhythmic [EPC] |
2 |
0.0000 |
| 23 |
Expectorant [EPC] |
4 |
0.0000 |
| 24 |
CD20-directed Cytolytic Antibody [EPC] |
6 |
0.0000 |
| 25 |
Angiotensin 2 Receptor Blocker [EPC] |
6 |
0.0000 |
| 26 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 27 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 28 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 29 |
Dihydropyridine Calcium Channel Blocker [EPC] |
5 |
0.0000 |
| 30 |
HER2/neu Receptor Antagonist [EPC] |
1 |
0.0000 |
| 31 |
Folate Analog Metabolic Inhibitor [EPC] |
5 |
0.0000 |
| 32 |
Platinum-based Drug [EPC] |
3 |
0.0000 |
| 33 |
Loop Diuretic [EPC] |
5 |
0.0000 |
| 34 |
5-alpha Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 35 |
Antirheumatic Agent [EPC] |
1 |
0.0000 |
| 36 |
HMG-CoA Reductase Inhibitor [EPC] |
3 |
0.0000 |
| 37 |
Corticosteroid [EPC] |
10 |
0.0000 |
| 38 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 39 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 40 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 41 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 42 |
Atypical Antipsychotic [EPC] |
3 |
0.0000 |
| 43 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 44 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 45 |
Interferon beta [EPC] |
1 |
0.0000 |
| 46 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 47 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 48 |
Alkylating Drug [EPC] |
1 |
0.0000 |
| 49 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 50 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 51 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 52 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |
| 53 |
Benzodiazepine [EPC] |
1 |
0.0000 |